Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:Any chance...

[chipmuki1234567]

Look at free cash flow and Q/Q cash usage. Unlikely this will  be the last. All interest payments are being made via shares. And they took 3 sales directors in for US, if that does not pan out, major dilution on the way.

The company has zero creditbility and cannot offer shares in the open market, it will sink them. Management also has skin in the game, hence the purchases in every placement to maintain ownership %. Further, new investors would most likely demand it. Citagenix was a horrible purchase thus far. Management could have pursued a merger, but didn't to retain control. the idea probably was to use citagenix to keep some validity in the share price to be able to get the funds to continue. but would you sell your profitable company for shares and lose control? nope, so they had to pick from the garbage bin.  Citagenix has been around from the late 90s and look at their F/S prior to acquisition... its a joke.

Goodman cleaned his hands of this and the contract with Antibe is cheap, so if it pans out great, but he is not involved. He's got bigger fish to fry.

They will push off a few milestones in March and raise more money in the summer, because $2.7M is joke as well (they would need 10 - 15M). a reverse split after the deal in 2018 summer at best. If anyone thinking about buying more, I suggest don't bother. This thing will get cheaper next winter once interest rates really start moving.